Ishita Drugs And Industries (BOM:524400) ROCE %: 10.19% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524400 Ishita Drugs And Industries Ltd BOM:524400
73 GF Score
Price ₹71.79
GF Value ₹78.36
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Ishita Drugs And Industries ROCE %?

Ishita Drugs And Industries BOM:524400 +1.00% 73 ROCE % is 10.19% as of Mar. 2026. GuruFocus rates BOM:524400 with a GF Score™ of 73/100 and a GF Value™ of ₹78.36 (Fairly Valued). The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Ishita Drugs And Industries's annualized ROCE % for the quarter that ended in Mar. 2026 was 10.19%.

Ishita Drugs And Industries  (BOM:524400) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Ishita Drugs And Industries ROCE % Related Terms

Ishita Drugs And Industries ROCE % Historical Data

* Premium members only.

The historical data trend for Ishita Drugs And Industries's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ishita Drugs And Industries ROCE % Chart

Ishita Drugs And Industries Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.73 9.16 10.97 11.78 10.12

Ishita Drugs And Industries Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.62 15.08 7.96 7.34 10.19
BOM:524400
73GF Score
Ishita Drugs And Industries Ltd BOM:524400
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ishita Drugs And Industries ROCE % Calculation

Ishita Drugs And Industries's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=11.392/( ( (162.958 - 54.048) + (126.037 - 9.885) )/ 2 )
=11.392/( (108.91+116.152)/ 2 )
=11.392/112.531
=10.12 %

Ishita Drugs And Industries's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=11.832/( ( (0 - 0) + (126.037 - 9.885) )/ 1 )
=11.832/( ( 0 + 116.152 )/ 1 )
=11.832/116.152
=10.19 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 10.19% mean?
Ishita Drugs And Industries (BOM:524400) has a ROCE % of 10.19% as of Mar. 2026.
Is Ishita Drugs And Industries' ROCE % too high?
Ishita Drugs And Industries' current ROCE % is 10.19%. The Drug Manufacturers industry median ROCE % is 7.06. Ishita Drugs And Industries' value of 10.19% is 44.3% above this industry median. Overall, Ishita Drugs And Industries has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ishita Drugs And Industries' ROCE % compare to ZTS and UTHR?
Ishita Drugs And Industries' ROCE % of 10.19% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.06. Ishita Drugs And Industries' value of 10.19% is 44.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.06, based on 962 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ishita Drugs And Industries's current ROCE % of 10.19% is 44.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ishita Drugs And Industries's current ROCE % is 10.19%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ishita Drugs And Industries stock overvalued right now?
Based on GuruFocus' analysis, Ishita Drugs And Industries (BOM:524400) is currently considered Fairly Valued. The stock's GF Value™ is ₹78.36, compared to a current price of ₹71.79 — trading 8.4% below its estimated fair value. The current ROCE % is 10.19% and 44.3% above the Drug Manufacturers industry median of 7.06. Ishita Drugs And Industries' overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Ishita Drugs And Industries (BOM:524400), the current ROCE % is 10.19% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ishita Drugs And Industries (BOM:524400) Overvalued in 2026?

Based on GuruFocus' analysis, Ishita Drugs And Industries stock appears to be undervalued. The current stock price of ₹71.79 is trading 8.4% below its estimated GF Value™ of ₹78.36. GuruFocus considers Ishita Drugs And Industries to be Fairly Valued.

Key valuation signals for BOM:524400:

  • ROCE %: 10.19%
  • GF Value™: ₹78.36 vs. price of ₹71.79 (8.4% below fair value)
  • GF Score™: 73/100 with 3 warning signs
  • Industry Position: 44.3% above the Drug Manufacturers median

No single metric tells the full story. See the BOM:524400 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ishita Drugs And Industries Business Description

Address C.G. Road, 401, 3rd Eye -II, Opposite Parimal Garden, Ahmedabad, GJ, IND, 380006
Ishita Drugs And Industries Ltd is engaged in the business of manufacturing various APIs and drug intermediates. The company supplies its products to various pharmaceutical companies and is also being exported to various countries across the world. The company has three manufacturing facilities located in the state of Gujarat, two for APIs and drug intermediates at Ahmedabad and Surendranagar, and one for finished pharmaceutical formulations at Mehsana.
73GF Score

Get the complete analysis for BOM:524400

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹71.79
Price
₹78.36
GF Value